Myeloma, plasma-cell

Clinical trials for Myeloma, plasma-cell explained in plain language.

Never miss a new study

Get alerted when new Myeloma, plasma-cell trials appear

Sign up with your email to follow new studies for Myeloma, plasma-cell, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Engineered immune cells take aim at Hard-to-Treat blood cancer

Disease control Completed

This early-phase trial tested a new gene therapy for multiple myeloma, a blood cancer that often becomes resistant to standard treatments. Researchers took participants' own immune T cells, modified them in the lab to recognize a protein called BCMA on myeloma cells, and infused …

Matched conditions: MYELOMA, PLASMA-CELL

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Myeloma, plasma-cell

Get alerted when new Myeloma, plasma-cell trials appear

Engineered immune cells take aim at Hard-to-Treat blood cancer